These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3389211)

  • 1. [Comparative study of 62 patients randomly treated with adriamycin or cisplatin as chemoprophylaxis of their superficial bladder carcinoma].
    Iborra Juan I; Monrós Lliso JL; Ricós Torrent JV; Mazcuñan Fuentes F; Casanova Ramón-Borja J; Solsona Narbón E
    Actas Urol Esp; 1988; 12(1):20-4. PubMed ID: 3389211
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL; Ojea A; Jamardo D; Figueiredo L
    Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B; Sánchez A; Boronat F; Gallego J; Moreno B; Alonso M; Martínez R; Vera CD; Jiménez JF
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
    Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF
    Actas Urol Esp; 1989; 13(1):41-3. PubMed ID: 2496584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of the recurrence of bladder tumors with local adriamycin therapy].
    Somogyi L; Török A; Bors G; Frang D
    Orv Hetil; 1984 Oct; 125(41):2503-6. PubMed ID: 6493764
    [No Abstract]   [Full Text] [Related]  

  • 8. Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumor.
    Llopis B; Gallego J; Mompó JA; Boronat F; Alonso M; Moreno B; Jiménez JF
    Eur Urol; 1986; 12(4):253-6. PubMed ID: 3091370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of recurrence in non-invasive bladder carcinoma. Experiences with 400 patients].
    Burk K; Troller RM; Pittner P
    Urologe A; 1983 Sep; 22 Suppl():332-6. PubMed ID: 6356556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.
    Jauhiainen K; Alfthan O
    Ann Chir Gynaecol; 1984; 73(4):206-10. PubMed ID: 6508201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of adriamycin and thiotepa in the chemoprophylaxis of superficial bladder tumors].
    Salinas Sánchez AS; Moreno Avilés J; Pérez Albacete M; Salmerón Lopez-Rua J; Guardiola Más A; Server Falgas G
    Actas Urol Esp; 1989; 13(2):99-102. PubMed ID: 2499166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results and long-term course of superficial bladder carcinomas treated with local adriamycin. Apropos of 69 cases].
    Iborra I; Mazcuñán F; Monros JL; Ricos JV; Solsona E
    Arch Esp Urol; 1987 Sep; 40(7):455-60. PubMed ID: 3688987
    [No Abstract]   [Full Text] [Related]  

  • 13. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C
    Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemoprophylaxis of superficial bladder tumors. Results of the EORTC study].
    Bouffioux C; Denis L; Debruyne F; Kurth KH; Schulman C
    Acta Urol Belg; 1986; 54(2):175-87. PubMed ID: 3728219
    [No Abstract]   [Full Text] [Related]  

  • 16. Experiences on the local adriamycin treatment of bladder tumours.
    Somogyi L; Török A; Bors G; Frang D
    Acta Chir Hung; 1987; 28(2):79-85. PubMed ID: 3618056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
    Gogna NK; Matthews JH; Turner SL; Mameghan H; Duchesne GM; Spry N; Berry MP; Keller J; Tripcony L;
    Radiother Oncol; 2006 Oct; 81(1):9-17. PubMed ID: 17011058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
    Flamm J; Grof F
    Urologe A; 1985 Jan; 24(1):31-5. PubMed ID: 4039083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristic and effective usage of adriamycin].
    Horiuchi K; Akimoto M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
    Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.